Rovida Investment Management Ltd Buys New Position in ASP Isotopes Inc. (NASDAQ:ASPI)

Rovida Investment Management Ltd purchased a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPIFree Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 218,972 shares of the company’s stock, valued at approximately $990,000. ASP Isotopes makes up 0.3% of Rovida Investment Management Ltd’s holdings, making the stock its 18th largest holding. Rovida Investment Management Ltd owned approximately 0.31% of ASP Isotopes as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of ASP Isotopes during the third quarter worth approximately $6,249,000. Philadelphia Financial Management of San Francisco LLC increased its stake in ASP Isotopes by 158.3% during the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after purchasing an additional 607,893 shares in the last quarter. Geode Capital Management LLC raised its holdings in ASP Isotopes by 42.7% during the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock worth $3,110,000 after buying an additional 334,836 shares during the last quarter. Walleye Capital LLC bought a new position in shares of ASP Isotopes in the third quarter valued at $536,000. Finally, State Street Corp grew its holdings in shares of ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after buying an additional 96,604 shares during the last quarter. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Price Performance

Shares of NASDAQ ASPI opened at $4.43 on Tuesday. The stock has a market cap of $316.26 million, a price-to-earnings ratio of -7.26 and a beta of 3.66. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The firm’s 50-day simple moving average is $5.07 and its 200 day simple moving average is $4.88.

About ASP Isotopes

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

See Also

Institutional Ownership by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.